AXA IM US Enhanced Index Eq QI M $ Acc |
Performance History | 30/04/2025 |
Growth of 1,000 (EUR) |
![]() | Fund | 38.4 | -13.2 | 19.4 | 31.8 | -14.3 |
![]() | +/-Cat | 3.8 | 1.1 | -0.7 | 2.7 | -0.4 |
![]() | +/-Idx | 2.9 | 1.5 | -2.6 | -1.1 | -0.8 |
Category: US Large-Cap Blend Equity | ||||||
Benchmarks: Morningstar US Large-Mid NR... |
Key Stats | ||
NAV 07/05/2025 | USD 76.43 | |
Day Change | 0.27% | |
Morningstar Category™ | US Large-Cap Blend Equity | |
ISIN | IE00B3DJ3161 | |
Fund Size (Mil) 07/05/2025 | USD 1432.59 | |
Share Class Size (Mil) 07/05/2025 | USD 505.78 | |
Max Initial Charge | - | |
Ongoing Charge 21/02/2025 | 0.05% |
Investment Objective: AXA IM US Enhanced Index Eq QI M $ Acc |
The investment objective of the Fund is to provide long-term capital appreciation with a total return greater than the return of the S&P 500 Index (the “Index”) on a rolling three-year basis. This Sub-Fund will primarily (meaning not less than 75% of its Net Asset Value) invest in equity securities traded principally on Regulated Markets that are issued by companies that have their registered office or carry out a predominant portion of their economic activity (meaning not less than 51%) in the US. It is intended that this Sub-Fund will be substantially fully invested in such equity securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 31/07/2020 | ||
Inception Date 03/10/2003 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 TR USD | Morningstar US Large-Mid NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for AXA IM US Enhanced Index Eq QI M $ Acc | 30/04/2025 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 6.75 |
![]() | ![]() | 6.28 |
![]() | ![]() | 5.75 |
![]() | ![]() | 3.53 |
![]() | ![]() | 3.33 |
![]() | ||
![]() ![]() ![]() | ||
AXA IM US Enhanced Index Eq QI M $ Acc |